With evolving requirements under MDR and IVDR, companies must adopt proactive regulatory strategies early in the development process.
Successful market entry depends on understanding classification rules, clinical evidence requirements, post-market surveillance, and quality management systems. Digital health solutions also face added complexity related to software validation, cybersecurity, and data protection.
Educational workshops, expert panels, and regulatory keynotes at industry events help innovators stay informed and prepared. By engaging with regulatory specialists and peers, companies can reduce risk, accelerate approvals, and ensure long-term product success in Europe.
